Agios Pharmaceuticals (AGIO) Receivables - Other (2016 - 2025)
Historic Receivables - Other for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q4 2025 value amounting to $10.6 million.
- Agios Pharmaceuticals' Receivables - Other rose 15741.06% to $10.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.6 million, marking a year-over-year increase of 15741.06%. This contributed to the annual value of $10.6 million for FY2025, which is 15741.06% up from last year.
- Per Agios Pharmaceuticals' latest filing, its Receivables - Other stood at $10.6 million for Q4 2025, which was up 15741.06% from $5.0 million recorded in Q3 2025.
- Agios Pharmaceuticals' Receivables - Other's 5-year high stood at $10.6 million during Q4 2025, with a 5-year trough of $1.2 million in Q3 2023.
- Over the past 5 years, Agios Pharmaceuticals' median Receivables - Other value was $3.6 million (recorded in 2024), while the average stood at $4.2 million.
- As far as peak fluctuations go, Agios Pharmaceuticals' Receivables - Other tumbled by 6883.94% in 2023, and later skyrocketed by 16513.61% in 2024.
- Agios Pharmaceuticals' Receivables - Other (Quarter) stood at $7.0 million in 2021, then crashed by 68.44% to $2.2 million in 2022, then grew by 27.38% to $2.8 million in 2023, then skyrocketed by 46.23% to $4.1 million in 2024, then soared by 157.41% to $10.6 million in 2025.
- Its Receivables - Other stands at $10.6 million for Q4 2025, versus $5.0 million for Q3 2025 and $5.0 million for Q2 2025.